AIM IMMUNOTECH INC. – Trademark Portfolio

Entity Type: 03

AIM IMMUNOTECH INC. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered and 2 are pending. Notable registered marks include ALFERON, AMPLIGEN, and AIM IMMUNOTECH. The owner is based in OCALA, FL.

2117 SW HIGHWAY 484

OCALA, FL 34473

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AIM IMMUNOTECH INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (13 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (7 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does AIM IMMUNOTECH INC. have?

AIM IMMUNOTECH INC. has 13 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 pending, 7 abandoned.

What trademark classes does AIM IMMUNOTECH INC. file in?

AIM IMMUNOTECH INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are AIM IMMUNOTECH INC.'s most well-known trademarks?

AIM IMMUNOTECH INC.'s registered trademark portfolio includes well-known marks such as ALFERON, AMPLIGEN, and AIM IMMUNOTECH. These are among 4 currently registered trademarks in the portfolio.

What is AIM IMMUNOTECH INC.'s trademark registration success rate?

AIM IMMUNOTECH INC. has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 2 applications are pending review.